Compare CQP & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CQP | CNC |
|---|---|---|
| Founded | 2003 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.3B | 33.1B |
| IPO Year | 2006 | 2001 |
| Metric | CQP | CNC |
|---|---|---|
| Price | $63.48 | $64.40 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 14 | 21 |
| Target Price | $60.00 | ★ $71.78 |
| AVG Volume (30 Days) | 99.7K | ★ 3.1M |
| Earning Date | 10-29-2026 | 10-27-2026 |
| Dividend Yield | ★ 5.17% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.07 | ★ 5.30 |
| Revenue | $10,758,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $4.67 | $11.22 |
| Revenue Next Year | $0.85 | N/A |
| P/E Ratio | $902.21 | ★ $12.06 |
| Revenue Growth | ★ 23.60 | 19.44 |
| 52 Week Low | $49.53 | $31.63 |
| 52 Week High | $71.25 | $69.63 |
| Indicator | CQP | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 50.46 |
| Support Level | $62.39 | $63.36 |
| Resistance Level | $66.84 | $68.67 |
| Average True Range (ATR) | 1.70 | 1.88 |
| MACD | -0.23 | -0.06 |
| Stochastic Oscillator | 50.58 | 48.59 |
Cheniere Energy Partners is a liquefied natural gas producer operating one facility in Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed- and variable-fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. The profit generated through those activities is split with parent and operator Cheniere Energy.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.